Clarence J. Maring
AbbVie (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, Monoclonal and Polyclonal Antibodies Research, Influenza Virus Research Studies, Hepatitis B Virus Studies
Most-Cited Works
- → Chiral induction in the cyclocondensation of aldehydes with siloxydienes(1983)158 cited
- → In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir(2017)136 cited
- → Chelation-controlled facially selective cyclocondensation reactions of chiral alkoxy aldehydes: syntheses of a mouse androgen and of a carbon-linked disaccharide(1985)131 cited
- → Influenza Neuraminidase Inhibitors: Structure-Based Design of a Novel Inhibitor Series(2003)128 cited
- → Discovery of ABT-267, a Pan-Genotypic Inhibitor of HCV NS5A(2014)126 cited
- → Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro(2005)120 cited
- → In Vitro Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor(2014)119 cited
- → In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication(2002)101 cited
- → A new approach to the synthesis of hexoses: an entry to (.+-.)-fucose and (.+-.)-daunosamine(1985)81 cited
- → Structure-Based Characterization and Optimization of Novel Hydrophobic Binding Interactions in a Series of Pyrrolidine Influenza Neuraminidase Inhibitors(2005)59 cited